CVS to expand access to naloxone in Oregon, Washington
PORTLAND, Ore. -- CVS pharmacies will expand access to naloxone, an opioid overdose-reversal drug in seven states, including Oregon and Washington, starting this summer.
CVS' program establishes a standing order with a physician in the state, which allows a pharmacist to dispense naloxone to patients without an individual prescription.
The expansion will come to Oregon in mid-July and Washington in early August.
"Expanding access to the overdose-reversal drug naloxone is a critical part of our national strategy to stop the prescription drug and heroin overdose epidemic - along with effective prevention, treatment, and enforcement," said Michael Botticelli, Director of National Drug Control Policy. "Thanks to efforts on naloxone like those announced today by CVS Health, more Americans will have access to this lifesaving drug."